1. Altered primary chromatin structures and their implications in cancer development

   • Angelo Ferraro

   Review 23 March 2016 Pages: 195 - 210

2. Simultaneous detection of circulating immunological parameters and tumor biomarkers in early stage breast cancer patients during adjuvant chemotherapy

   • B. Rovati
   • S. Mariucci
   • P. Pedrazzoli

   OriginalPaper 14 January 2016 Pages: 211 - 228

   

3. Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation

   • Hannah J. Anderson
   • Deni S. Galileo

   Original Paper 16 February 2016 Pages: 229 - 242

   

4. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas

   • José García-Solano
   • María Eulalia García-Solano
   • Pablo Conesa-Zamora

   Original Paper 01 February 2016 Pages: 243 - 252

   

5. Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker

   • Renato José Silva-Oliveira
   • Viviane Aline Oliveira Silva
   • Rui Manuel Reis

   Original Paper 26 February 2016 Pages: 253 - 263

   

6. A novel curcumin-like dienone induces apoptosis in triple-negative breast cancer cells

   • Elisa Robles-Escajeda
   • Umashankar Das
   • Renato J. Aguilera

   Original Paper 26 February 2016 Pages: 265 - 277

   

7. Tumor-specific promoter-driven adenoviral therapy for insulinoma

   • Alan Wei-Shun Tseng
   • Chiachen Chen
   • Michael S. Lan

   Original Paper 22 February 2016 Pages: 279 - 286

   

8. Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report

   • Demetrios N. Karatzas
   • Konstantinos Xanthopoulos
   • George Mosialos

   Short Communication 04 April 2016 Pages: 287 - 293